Home Newsfeeds Needham Maintains Buy on Intra-Cellular Therapies, Raises Price Target to $67

Needham Maintains Buy on Intra-Cellular Therapies, Raises Price Target to $67

Needham analyst Ami Fadia maintains Intra-Cellular Therapies (NASDAQ:ITCI) with a Buy and raises the price target from $65 to $67.

byBenzinga Newsdesk

August 10, 2022

1 minute read

Needham analyst Ami Fadia maintains Intra-Cellular Therapies (NASDAQ:ITCI) with a Buy and raises the price target from $65 to $67.

Wells Fargo Maintains Equal-Weight on New Jersey Resources, Lowers Price Target to $50

By Benzinga Newsdesk

January 10, 9:25 AM

Wells Fargo analyst Sarah Akers maintains New Jersey Resources (NYSE:NJR) with a Equal-Weight and lowers the price target from $51 to $50.

NJR

Joby And Toyota Expand Partnership With Long-Term Supply Agreement For Key Powertrain And Actuation Components

By Happy Mohamed

April 27, 8:10 AM

Joby Aviation, Inc. (NYSE:JOBY), a company developing all-electric aircraft for commercial passenger service, today announced it has signed a long-term agreement with Toyota Motor Corporation Inc. (NYSE:TM) to supply key

JOBY

News

Toyota Announces Statement Concerning The Production Order System Malfunction

By Happy Mohamed

September 6, 11:56 AM

https://global.toyota/en/newsroom/corporate/39732568.html We would like to apologize once again to our customers, suppliers, and related parties for any inconvenience caused by the suspension of our domestic plants as a

MedTech Bioventus’ Stabilization Sparks Analyst Confidence, Earns Upgrade And Price Target Boost

By Vandana Singh

December 7, 4:35 PM

Canaccord Genuity has upgraded Biomedical Devices and Services company Bioventus Inc (NASDAQ: BVS), highlighting greater insight into the progress of the turnaround and plans for future investment and growth.

BVS

Needham Maintains Buy on Intra-Cellular Therapies, Raises Price Target to $67

Related Posts

Wells Fargo Maintains Equal-Weight on New Jersey Resources, Lowers Price Target to $50

Joby And Toyota Expand Partnership With Long-Term Supply Agreement For Key Powertrain And Actuation Components

Toyota Announces Statement Concerning The Production Order System Malfunction

MedTech Bioventus’ Stabilization Sparks Analyst Confidence, Earns Upgrade And Price Target Boost